000 | 01916 a2200565 4500 | ||
---|---|---|---|
005 | 20250513193238.0 | ||
264 | 0 | _c19991102 | |
008 | 199911s 0 0 eng d | ||
022 | _a0021-9738 | ||
024 | 7 |
_a10.1172/JCI6740 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOstendorf, T | |
245 | 0 | 0 |
_aVEGF(165) mediates glomerular endothelial repair. _h[electronic resource] |
260 |
_bThe Journal of clinical investigation _cOct 1999 |
||
300 |
_a913-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAneurysm _xpathology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 |
_aCornea _xblood supply |
650 | 0 | 4 |
_aEndothelial Growth Factors _xpharmacokinetics |
650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
650 | 0 | 4 |
_aGlomerulonephritis _xpathology |
650 | 0 | 4 |
_aGlomerulonephritis, Membranoproliferative _xpathology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Glomerulus _xblood supply |
650 | 0 | 4 |
_aLymphokines _xpharmacokinetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 |
_aPolyethylene Glycols _xpharmacology |
650 | 0 | 4 |
_aProtein Isoforms _xpharmacokinetics |
650 | 0 | 4 | _aProteinuria |
650 | 0 | 4 |
_aPuromycin Aminonucleoside _xtoxicity |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aRenal Circulation |
650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
650 | 0 | 4 | _aVascular Endothelial Growth Factors |
700 | 1 | _aKunter, U | |
700 | 1 | _aEitner, F | |
700 | 1 | _aLoos, A | |
700 | 1 | _aRegele, H | |
700 | 1 | _aKerjaschki, D | |
700 | 1 | _aHenninger, D D | |
700 | 1 | _aJanjic, N | |
700 | 1 | _aFloege, J | |
773 | 0 |
_tThe Journal of clinical investigation _gvol. 104 _gno. 7 _gp. 913-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI6740 _zAvailable from publisher's website |
999 |
_c10467399 _d10467399 |